Stock ORY ORYZON GENOMICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Oryzon Genomics S.A.

Equities

ORY

ES0167733015

Market Closed - BME
Other stock markets
 16:35:03 14/05/2024 BST 		5-day change 1st Jan Change
2.03 EUR +4.00% Intraday chart for Oryzon Genomics S.A. +4.00% +7.52%
05-06 Oryzon Genomics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-22 Oryzon Genomics, S.A. Secures Another Important Patent for its Lead CNS Asset, Vafidemstat CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ORYZON GENOMICS S.A.
Other Biotechnology & Medical Research
+4.00%+4.00%+7.52%-1.46%-50.06% 121M
Neutral
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ORY Stock
  4. Charts Oryzon Genomics S.A.
  5. Comparison Chart